As research continues, we expect to see these protocols refined and perhaps even integrated into standard care
Contribution of the authors Juan Daniel Daz Garca: contributed with the original idea and the process of preparation of the review regarding the search for references, selection of information, structure of the review (abstract, introduction, development, conclusion, bibliography, tables and figures) and changes during its publication process Emmanuel Arceo: contributed with the search and development of the review
The standard initial loading dose is 1,000 mcg administered intramuscularly (IM) once weekly for 4 weeks
Self-reported adverse effects from patients who used BPC-157 before the restrictions include injection site pain, joint discomfort, anxiety, heart palpitations, insomnia, fatigue, and mood changes
Tracking, Delivery, and Carrier Events Tracking information will be provided when available